Objective: To test the antioxidant effect of therapeutic doses of dipyridamole on cellular membranes, human erythrocytes were chosen 21 as an appropriate model to study oxidative stress induced by cumene hydroperoxide because of their high content in heme-Fe . 
Introduction
the scavenging of peroxyl radicals. Pedulli et al. [12] suggested an alternative antioxidant mechanism of electron Dipyridamole is a pyrimidopyrimidine compound with transfer, different from the classical chain breaking effect antithrombotic and vasodilating actions [1, 2] , effective in which operates in the case of phenol or amine antioxidant the secondary prevention of cerebrovascular disease [3] .
and involves the transfer of hydrogen atoms to peroxyl Although this drug has been used for many years, its radicals. mechanism of action is still unclear [4] . It has been
The involvement of reactive oxygen species and lipid suggested to inhibit platelet phosphodiesterase [5] to peroxidation in disease states such as atherosclerosis [13-stimulate the release of prostacyclin [6] [7] [8] , and to inhibit 15], ischemia-reperfusion injury [16, 17] , and sickle cell the carrier mediated transport of adenosine [9, 10] . has focused much scientific interest on ly, it has also been reported to have quite significant lipid peroxidation processes, outlining a possible role for antioxidant activity in vitro by electron spin resonance antioxidant drugs in the care or prevention of these (ESR) studies [11, 12] .
diseases. In particular, Iuliano et al. [11] have demonstrated that
It has been hypothesized that the antioxidant effect of the antioxidant activity of dipyridamole is mainly due to dipyridamole may contribute to its therapeutic virtues [4, 11] . However, the entity of the dipyridamole anti-radical To the pellet obtained after centrifugation (1600 g, 10 was obtained from each subject. Hematocrit was determin, 48C) 6 ml of 1% RBC suspension 0.5 ml H O was 2 mined and the cells were centrifuged at 400 g for 10 min at added. Proteins were precipitated by the addition of 1 ml 21 21 48C, washed three times in Ca and Mg free Hanks' of fresh metaphosphoric acid solution (1.67 g metaphosbuffer and suspended in Hanks' buffer. RBCs oxidative phoric acid, 0.2 g EDTA-disodium salt and 30 g NaCl in stress was induced as described by van den Berg et al.
100 ml H O). The supernatant was separated from protein 2 [24]. precipitate after 5 min by centrifugation and subsequently filtered on Puradisc 25AS (Whatman), 0.2 mm pore size.
Measurement of oxidation kinetics of cis-PnA
An aliquot of 0.5 ml of supernatant was combined with 0.5 21 ml of 300 mmol l Na HPO , and its blank was obtained 2 4 The oxidative degradation of PnA was monitored in a by combining 0.5 ml of supernatant with 0.5 ml of H O. 2 continuous fluorescence assay on a spectrofluorimeter Then, 100 ml DTNB solution (20 mg DTNB in 100 ml 1% (excitation 313 nm; emission 455 nm). Full methodological sodium citrate) was added to the blank and to the sample. details are given elsewhere [24, 25] . The fluorescence Sample absorbance was read against the blank absorbance signal was calibrated on 3 ml of a 1% RBC suspension in at 412 nm.
2.6. Vitamin E extraction procedure fluorescence emission in the absence or in the presence of 21 21 4 mmol l and 12.5 mmol l dipyridamole. To 7 ml of the RBCs incubation suspensions, 50 ml of Drug addition 5 min after exposure to the oxidant 21 45 mmol l butylated hydroxytoluene were added, and suppresses the probe fluorescence decay for a time proporimmediately centrifuged in a table top centrifuge. Vitamin tional to the drug concentration ( Fig. 1, inset ). E was extracted from RBC pellets according to the The sensitivity towards oxidative stress was variable procedure by Lang et al. [27] . Vitamin E concentrations among subjects, both on vitamin E consumption (ranging were assessed by HPLC with fluorimetric detection (excitafrom 28 to 55%, n511) and thiol oxidation (ranging from tion 286 nm, emission 330 nm). The HPLC analysis was 54 to 77%, n510).
21
performed on a ODS C-18 column (Beckman) using In the absence of the oxidant, 20 mmol l dipyridamole 21 6 methanol as eluent at 1 ml min . 
Results
Increasing doses of dipyridamole, ranging from 2 to 20 21 mmol l preserve vitamin E in a dose-dependent fashion Lipid peroxidation of red blood cell membranes, in- (Fig. 2) . Vitamin E content was 70.6%61.7, 77.2%63.9, The method we used to assess the thiol content is unable to distinguish the glutathione (GSH) from the other free thiols; however, it represents a fast and easy tool to observe the heavy effect of oxidative stress at cytosolic level. Free thiol oxidation can be the result of direct radical attack but can also occur indirectly through GSHrequiring repair processes such as the reduction of oxidised membrane protein thiol group. van den Berg et al. [24] , using the same method, described (even if they did not show it) a rapid and massive consumption of GSH induced by both cumene hydroperoxide and hydrogen peroxide, cytosolic thiol content could be due in minimal part to the sensitivity of the method we used and to a larger extent on the capacity of cumene to overwhelm GSH-dependent 21 10 and 20 mmol l dipyridamole, thiol concentration went antioxidant factors. The cytosolic antioxidant effect of the up to 41.9%61.8 and 50.1%68.3, respectively (Fig. 3) .
dipyridamole is the consequence of the reduction of radical species forming at the membrane site. Moreover, the moderate effect of the drug on free thiol content could also 4. Discussion be due to the capacity of the oxidised GSH to move out the cells. The peroxyl radical scavenging activity of dipyridamole, Our study confirms and expands previous observations demonstrated in vitro by ESR studies [11, 12] , was condemonstrating the powerful antioxidant effects of firmed by our experiments in red blood cells submitted to dipyridamole [11, 12, 29] . However, some peculiarities of an oxidative stress induced by cumene hydroperoxide. The the present study perhaps help to put this antioxidant effect initiation of lipid peroxidation by cumene hydroperoxide in a clinically realistic framework. First, the model used 21 requires a metal ion cofactor (i.e. Fe -heme) in fact was the ex vivo evaluation of red blood cells, rather than a cis-PnA is not degraded in erythrocyte ghost membranes in pure in vitro assay of antioxidant activity. Cellular memthe absence of the metal ion [25] . Cumene-induced peroxibranes were challenged with acute chemical oxidative dation of cis-PnA is accompanied by hemoglobin oxidastress, and, in this model, dipyridamole acted as a potent tion (met-hemoglobin and hemicrome formation) [24, 25] .
antioxidant shield. Second, the explored dose concentration In this model the membrane soluble oxidant reacts gradualrange of dipyridamole was chosen in order to reproduce ly with both membrane-bound hemoglobin and cytosolic, the whole spectrum which can be found with different 21 initially yielding cumene alkoxyl radicals that can initiate clinical therapeutic applications: from 2 mmol l achieved lipid peroxidation, vitamin E consumption and thiol oxidain plasma with 200 mg p.o. (the elective dosage for tion. In the present work dipyridamole, at pharmacological antiplatelet-neuroprotective applications) [10] up to 10-fold doses, was demonstrated to behave as an active quencher higher concentrations (achieved for cardiac surgery appliof peroxyl radicals due to its capability to extend the lag cations as an antiplatelet agent) [30] . Interestingly, an phase of cis-PnA peroxidation, and to reduce vitamin E antioxidant effect was observed over the full explored consumption in red blood cell membranes.
range, but with a steep dose-dependence, suggesting that In our assays on lipid peroxidation, dipyridamole was high intravenous dose regimens -such as those achieved added to cell suspension 5 min after the initiation of in a cardiac surgery theater -are probably required to oxidation. Since the drug takes time to be optimally recruit the full antioxidant drug potential. Third, the study incorporated into the membranes, it is reasonable to think design allowed us to gain an insight into the underlying that its protective action would be more effective with an pathways of the antioxidant effect. Such pathways are earlier drug treatment. However, our aim was to test the multiple and complex, involving a vitamin E sparing capacity of dipyridamole to act as a real chain-breaking effect, active quenching of peroxyl radicals and -despite compound once the process of lipid peroxidation had the inability of dipyridamole to cross the cell membranebegun.
saving of cytosolic thiols. In addition, the antioxidant Despite the inability of dipyridamole to penetrate the effect is due to dipyridamole per se and independent of cytosol [28], in our experimental conditions the antioxidant adenosine accumulation. effect of dipyridamole is spread also to cytosolic thiols.
Thereby, the antioxidant effect of dipyridamole is 
